Chancellor Rachel Reeves Intends Targeted Action on Household Expenses in Forthcoming Financial Plan
Chancellor Rachel Reeves has stated she is planning "targeted action to deal with cost of living pressures" in the forthcoming financial statement.
Speaking to the BBC, she stated that curbing inflation is a collective responsibility of both the administration and the Bank of England.
The UK's inflation rate is forecast to be the highest among the Group of Seven industrialized countries this calendar year and next.
Possible Utility Cost Interventions
It is understood the government could take action to reduce energy bills, for example by reducing the present 5% level of value-added tax charged on energy.
An additional approach is to reduce some of the policy costs currently included in household expenses.
Budgetary Constraints and Expert Predictions
The administration will receive the next draft from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much scope there is for these actions.
The view from the majority of economists is that Reeves will have to announce tax rises or budget cuts in order to meet her declared debt limits.
Previously on Thursday, analysis showed there was a £22 billion gap for the chancellor to address, which is at the more modest range of projections.
"There's a shared job between the Bank of England and the administration to bear down further on some of the sources of price increases," Reeves informed the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.
Tax Pledges and International Issues
While much of the focus has been on expected tax rises, the Treasury chief said the latest data from the fiscal watchdog had not changed her pledge to campaign commitments not to increase rates on earnings tax, sales tax or social security contributions.
She attributed an "uncertain global environment" with rising geopolitical and trade issues for the Budget revenue measures, probably to be focused on those "wealthiest."
International Economic Tensions
Commenting on concerns about the UK's commercial links with China she said: "The UK's national security invariably come first."
Recent statement by Chinese authorities to increase export controls on critical minerals and other materials that are essential for advanced tech manufacturing led American leader Donald Trump to threaten an further 100% tariff on imports from China, increasing the risk of an full-scale trade war between the two economic giants.
The US Treasury Secretary described China's decision "economic coercion" and "a global supply chain control attempt."
Questioned on considering the US offer to participate in its dispute with China, the Chancellor said she was "very concerned" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."
She said the decision was "harmful for the world economy and generates further challenges."
"In my view there are areas where we must challenge Chinese policies, but there are also important prospects to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that equilibrium appropriate."
The chancellor also confirmed she was working with international partners "on our own critical minerals approach, so that we are less reliant."
Health Service Drug Pricing and Funding
The Chancellor also recognized that the cost the NHS pays for drugs could go up as a consequence of current talks with the US government and its drugs companies, in exchange for reduced taxes and capital.
A number of the world's largest drug companies have said recently that they are either halting or abandoning projects in the United Kingdom, with several attributing the low prices they are obtaining.
Last month, the Science Minister said the price the health service pays for medicines would need to rise to halt businesses and pharmaceutical investment departing from the United Kingdom.
Reeves stated to media: "It has been observed because of the pricing regime, that drug testing, innovative medicines have not been provided in the United Kingdom in the way that they are in other EU nations."
"We want to guarantee that patients receiving treatment from the National Health Service are can receive the top life-saving treatments in the globe. And so we are looking at all of that, and... looking to obtain additional investment into the UK."